93 related articles for article (PubMed ID: 22525818)
1. Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells.
Choi CH; Park YA; Choi JJ; Song T; Song SY; Lee YY; Lee JW; Kim TJ; Kim BG; Bae DS
Gynecol Oncol; 2012 Jul; 126(1):124-31. PubMed ID: 22525818
[TBL] [Abstract][Full Text] [Related]
2. Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma.
Park YA; Choi CH; Do IG; Song SY; Lee JK; Cho YJ; Choi JJ; Jeon HK; Ryu JY; Lee YY; Kim TJ; Bae DS; Lee JW; Kim BG
Gynecol Oncol; 2014 Oct; 135(1):108-17. PubMed ID: 25014541
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer.
Guo R; Gu J; Zhang Z; Wang Y; Gu C
IUBMB Life; 2015 Jan; 67(1):42-53. PubMed ID: 25646808
[TBL] [Abstract][Full Text] [Related]
4. The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.
Park YA; Lee JW; Choi JJ; Jeon HK; Cho Y; Choi C; Kim TJ; Lee NW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):125-33. PubMed ID: 22015043
[TBL] [Abstract][Full Text] [Related]
5. The expression of the miRNA-200 family in endometrial endometrioid carcinoma.
Lee JW; Park YA; Choi JJ; Lee YY; Kim CJ; Choi C; Kim TJ; Lee NW; Kim BG; Bae DS
Gynecol Oncol; 2011 Jan; 120(1):56-62. PubMed ID: 21035172
[TBL] [Abstract][Full Text] [Related]
6. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
[TBL] [Abstract][Full Text] [Related]
7. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
[TBL] [Abstract][Full Text] [Related]
8. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE
Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928
[TBL] [Abstract][Full Text] [Related]
9. Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patients.
Sardo MA; Mandraffino G; Riggio S; D'Ascola A; Alibrandi A; Saitta C; Imbalzano E; Castaldo M; Cinquegrani M; Saitta A
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):933-8. PubMed ID: 20497421
[TBL] [Abstract][Full Text] [Related]
10. A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
Sookoian S; Castaño G; García SI; Viudez P; González C; Pirola CJ
Am J Gastroenterol; 2005 Mar; 100(3):636-42. PubMed ID: 15743363
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacogenetics of angiotensin system in non diabetic nephropathy].
Coto E; Marín R; Alvarez V; Praga M; Fernández Andrade C; Arias M; Poveda R; Vallés M; Galcerán JM; Luño J; Rivera F; Campistol JM
Nefrologia; 2005; 25(4):381-6. PubMed ID: 16231503
[TBL] [Abstract][Full Text] [Related]
12. Post-Transcriptional Control of Angiotensin II Type 1 Receptor Regulates Osteosarcoma Cell Death.
Zhao Y; Xu K; Liu P
Cell Physiol Biochem; 2018; 45(4):1581-1589. PubMed ID: 29482191
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis.
Price A; Lockhart JC; Ferrell WR; Gsell W; McLean S; Sturrock RD
Arthritis Rheum; 2007 Feb; 56(2):441-7. PubMed ID: 17265479
[TBL] [Abstract][Full Text] [Related]
14. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.
Tsuruta T; Kozaki K; Uesugi A; Furuta M; Hirasawa A; Imoto I; Susumu N; Aoki D; Inazawa J
Cancer Res; 2011 Oct; 71(20):6450-62. PubMed ID: 21868754
[TBL] [Abstract][Full Text] [Related]
15. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.
He S; Zeng S; Zhou ZW; He ZX; Zhou SF
Drug Des Devel Ther; 2015; 9():1103-75. PubMed ID: 25733820
[TBL] [Abstract][Full Text] [Related]
16. AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist.
Rhodes DR; Ateeq B; Cao Q; Tomlins SA; Mehra R; Laxman B; Kalyana-Sundaram S; Lonigro RJ; Helgeson BE; Bhojani MS; Rehemtulla A; Kleer CG; Hayes DF; Lucas PC; Varambally S; Chinnaiyan AM
Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10284-9. PubMed ID: 19487683
[TBL] [Abstract][Full Text] [Related]
17. [Expression and its clinical significance of hsa-miR-155 in serum of endometrial cancer].
Tan ZQ; Liu FX; Tang HL; Su Q
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):772-4. PubMed ID: 21176560
[TBL] [Abstract][Full Text] [Related]
18. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2-receptor expression and IP3 receptor and PKCepsilon proteins.
Xu Y; Menon V; Jugdutt BI
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):184-95. PubMed ID: 11967812
[TBL] [Abstract][Full Text] [Related]
20. Blocking angiotensin II Type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells.
Gong Q; Davis M; Chipitsyna G; Yeo CJ; Arafat HA
Pancreas; 2010 Jul; 39(5):581-94. PubMed ID: 20118823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
